Avacta Group (AVCT) Sets New 12-Month Low at $35.00

Shares of Avacta Group Plc (LON:AVCT) reached a new 52-week low during trading on Monday . The company traded as low as GBX 35 ($0.48) and last traded at GBX 35.50 ($0.49), with a volume of 0 shares traded. The stock had previously closed at GBX 35.50 ($0.49).

Separately, FinnCap reiterated a “corporate” rating and set a GBX 200 ($2.76) price objective on shares of Avacta Group in a research report on Monday, January 22nd.

How to Become a New Pot Stock Millionaire

In other Avacta Group news, insider Alastair Smith purchased 35,800 shares of the stock in a transaction on Tuesday, March 13th. The stock was bought at an average price of GBX 42 ($0.58) per share, for a total transaction of £15,036 ($20,773.69).

TRADEMARK VIOLATION NOTICE: This news story was originally posted by Enterprise Leader and is owned by of Enterprise Leader. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://theenterpriseleader.com/2018/04/02/avacta-group-avct-sets-new-12-month-low-at-35-00.html.

About Avacta Group

Avacta Group plc is a biotechnology company. Avacta’s focus is on its proprietary Affimer technology which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and general research and development. Affimer technology has been designed to address performance limitations of antibodies.

Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply